Spin-Off Research downgraded Holcim (HCMLY) to Sell from Hold with a $13.50 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCMLY:
- Amrize initiated with a Buy at Truist
- Holcim upgraded to Buy from Neutral at BofA
- Holcim resumed with an Overweight at JPMorgan
- Holcim upgraded to Overweight from Equal Weight at Morgan Stanley
- Holcim: A Buy Rating Backed by Strong Cash Generation, Decarbonization Leadership, and Strategic Growth Opportunities